Simcere Pharmaceutical Group Limited (HKG: 2096)

Simcere Pharmaceutical Group Revenue

Simcere Pharmaceutical Group had revenue of 3.11B CNY in the half year ending June 30, 2024, with 15.33% growth. This brings the company's revenue in the last twelve months to 6.34B, down -9.51% year-over-year. In the year 2023, Simcere Pharmaceutical Group had annual revenue of 6.61B with 4.49% growth.

• Revenue (ttm): 6.34B CNY
• Revenue Growth: -9.51%
• P/S Ratio: 2.68
• Revenue / Employee: 902.18K CNY
• Employees: 7,027
• Market Cap: 17.65B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	6.61B	283.72M	4.49%
Dec 31, 2022	6.32B	1.32B	26.49%
Dec 31, 2021	5.00B	491.00M	10.89%
Dec 31, 2020	4.51B	-527.94M	-10.48%
Dec 31, 2019	5.04B	522.45M	11.57%